Drossafol
Drossafol is a medicine authorised by Swissmedic under authorisation number 56272. The authorisation holder is Drossapharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 07 May 2003 and the authorisation is valid without a time limit. ATC code B03BB01 places the medicine in the group Antianemic preparations.
| Authorisation number | 56272 |
|---|---|
| Name | Drossafol |
| Full name | Drossafol, Tabletten |
| Authorisation holder | Drossapharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B03BB01 |
| First authorisation | 07 May 2003 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Drossafol, Tabletten | B | 07 May 2003 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 20 | Tablette(n) | B03BB01 | 06.07.3. | B |
| 3 | 100 | Tablette(n) | B03BB01 | 06.07.3. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Drossafol authorised in Switzerland?
Yes. Drossafol is authorised by Swissmedic under authorisation number 56272, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Drossafol have?
Drossafol is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Drossafol?
The authorisation holder is Drossapharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.